Johnson & Johnson has been ordered to pay $181 million to a Houston law firm that worked on behalf of the state of Arkansas in a Medicare fraud case against the company.
A Reuters story says that payment is part of a $1.2 billion settlement the company agreed to pay Arkansas in 2012, based on the state’s claims that Johnson & Johnson downplayed the risks of the antipsychotic drug Risperdal.
Arkansas alleged ...
continue reading...